APPLICATIONS PUBLISHED 9 APRIL 2003

Published: 1-Oct-2003

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492

  • B vitamin compsns that protect against cellular damage caused by ultraviolet light
    Planet Biotech 1299078*

  • Use of oligosaccharides to stimulate beta-endorphin production
    LVMH Recherche 1299081*

  • Low molecular weight polymeric compsns
    Genzyme Corp 1299083*

  • Liposomal antineoplastic drugs and uses therefore
    Inex Pharmaceuticals 1299084*

  • Improved liposomal camptothecins and uses thereof
    Inex Pharmaceuticals 1299085*

  • Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
    Hydromer 1299086*

  • Microspheres and adjuvants for DNA vaccine delivery
    Corixa Corp 1299087*

  • Tablet obtained by direct compression comprising 4-amino-1-hydroxy-butylidine-1,1'-bisphosphonic acid as active ingredient
    Leciva 1299088*

  • Drug delivery system for poorly water soluble drugs
    Kemestrie 1299089*

  • Oral pharmaceutical compsn with controlled release and prolonged absorption
    Flamel Technologies 1299090*

  • Matrix-controlled transdermal system for stable derivatives of ACE inhibitors
    Hexal 1299091*

  • Use of fluoroscein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chlorine channel
    University of Bristol 1299092*

  • Combinations of bisphosphonates, oestrogenic agents and optionally oestrogens
    Wyeth 1299093*

  • Selective androgen receptor modulators and methods for their identification, design and use
    Bristol-Myers Squibb 1299094*

  • Clear aqueous anaesthetic compsn
    Bharat Serums & Vaccines 1299095*

  • Prostaglandin compounds for treating congestive heart failure
    United Therapeutics Corp 1299096*

  • Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol
    Hormos Nutraceutical 1299097*

  • Use of fluoroscein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel
    University of Bristol 1299098*

  • Novel use of (R)-(-)-2-5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)-chromane and its physiologically acceptable salts
    Merck 1299099*

  • Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
    The University of Rochester 1299100*

  • Use of riluzole or its salts for preventing and treating adrenoleukodystrophy
    Aventis Pharma; Institut National de la Sante et de la Recherche Medicale (INSERM) 1299102*

  • 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors
    Aventis Pharma 1299103*

  • Tamper-resistant oral opioid agonist formulations
    Euro-Celtique 1299104*

  • Compsns comprising folic acid and zinc for improving male fertility
    N. V. Nuticia 1299105*

  • Method for treatment and prevention of mastitis
    Pharmacia & Upjohn 1299106*

  • Highly concentrated stable meloxicam solutions
    Boehringer Ingelheim 1299107*

  • A parasiticidal formulations and method of making this formulation
    Phoenix Scientific 1299108*

  • Bifunctional antibiotics
    The Scripps Research Institute 1299109*

  • Combined therapy against tumours comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
    Pharmacia 1299110*

  • Method for producing nematocidal compsn by heat treating a pH-adjusted fermentation broth
    Valent Biosciences 1299111*

  • Compsns for treating eye discomfort, containing herbals and/or nutritional supplements and/or minerals and/or vitamins
    Pharmacia Italie 1299112*

  • Use of the heat shock protein GP96
    Immatics Biotechnologies 1299113*

  • Diclofenac pharmaceutical compsn based on vitamin E, papain and hyaluronidase
    Topic Empreendimentos e Participacoes 1299114*

  • Methods and compsns for developing spore display systems for medicinal and industrial applications
    Maxygen 1299115*

  • Helicobacter pylori with modified lipopolysaccharide biosynthesis
    Chiron 1299116*

  • Vaccine against helicobacter pylori
    Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1299117*

  • Production and use of derivatised homoserine lactones
    K-Quay Enterprises 1299118*

  • Immunosuppressive compsns comprising an immunophilin-binding compound and a ginkgolide compound
    Haines, David; Tosaki, Arpad; Mahmoud, Fadia 1299119*

  • Compsns comprising a serotonin transporter inhibitor and a 5-HT1D antagonist
    Eli Lilly 1299120*

  • Thromboxane receptor antagonist containing formulations for potentiating organic nitrates having vasodilating activity
    Gupta, Sachin 1299121*

  • Combination of a COX-2 inhibitor and a vasomodulator for treating pain and headache pain
    Pharmacia 1299122*

  • Use of COX-2 inhibitors in the treatment and prevention of ocular COX-2 mediated disorders
    Pharmacia 1299123*

  • Compsn for aqueous stabilisation of fat-soluble vitamins
    Bertha, Andras 1299124*

  • Production, stabilisation and use of reduced forms of pharmaceutical compounds
    Hunter-Fleming 1299125*

  • Glutamic acid decarboxylase (GAD) delivery system for treating neurodegenerative diseases
    Neurologix 1299126*

  • The NIP3 family of proteins
    The University of Manitoba 1299127*

  • Cold anti-CD20 antibody/radiolabelled anti-CD22 antibody combination
    Idec Pharmaceuticals 1299128*

  • Stable radioiodine conjugates and methods for their synthesis
    Immunomedics 1299129*

  • A method for treating and preventing infectious diseases
    Lipid Sciences 1299130*

  • Materials for sterilising biological materials
    Clearant 1299131*

  • Limiting the presence of microorganisms using polymer-bound metal-containing compsns
    3M Innovative Properties 1299132*

  • Device for introducing active substances into ambient air
    Sara Lee/DE N.V. 1299133*

  • The use of honey in wound dressings
    Caskey, Phillip Royy 1299134*

  • Wound dressing comprising a therapeutically active agent
    CTP Cable Technology 1299135*

  • Implantable prostheses with improved mechanical and chemical properties
    Boston Scientific 1299136*

  • You may also like